tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

HUMA Stock Latest News

Humacyte Faces Financial Uncertainty: Potential Impact on Share Price and Capital
Company AnnouncementsHumacyte Faces Financial Uncertainty: Potential Impact on Share Price and Capital
35m ago
HUMA
Humacyte Reports Q3 2024 Results Amid FDA Review
PremiumCompany Announcements
Humacyte Reports Q3 2024 Results Amid FDA Review
1d ago
HUMA
Humacyte reports Q3 EPS (33c), consensus (25c)
PremiumThe Fly
Humacyte reports Q3 EPS (33c), consensus (25c)
2d ago
HUMA
Humacyte price target raised to $12 from $6 at H.C. Wainwright
PremiumThe Fly
Humacyte price target raised to $12 from $6 at H.C. Wainwright
5d ago
HUMA
Humacyte announces reuslts from V007 Phase 3 trial of ATEV in AV
PremiumThe Fly
Humacyte announces reuslts from V007 Phase 3 trial of ATEV in AV
13d ago
HUMA
Humacyte to host KOL event on he use of ATEV for AV access in hemodialysis
PremiumThe FlyHumacyte to host KOL event on he use of ATEV for AV access in hemodialysis
18d ago
HUMA
Hertz Global Holdings call volume above normal and directionally bullish
Premium
The Fly
Hertz Global Holdings call volume above normal and directionally bullish
20d ago
HUMA
Unusually active option classes on open October 18th
Premium
The Fly
Unusually active option classes on open October 18th
23d ago
MP
PG
Humacyte issues raised in 483 appear ‘fixable,’ says BTIG
PremiumThe Fly
Humacyte issues raised in 483 appear ‘fixable,’ says BTIG
23d ago
HUMA
Humacyte facility inspection likely not root cause of BLA delay, says TD Cowen
PremiumThe Fly
Humacyte facility inspection likely not root cause of BLA delay, says TD Cowen
23d ago
HUMA
Humacyte concerns raised in 483 not that big a deal, says Piper Sandler
PremiumThe Fly
Humacyte concerns raised in 483 not that big a deal, says Piper Sandler
23d ago
HUMA
FDA discloses summary of violations at Humacyte’s Durham, NC facility
PremiumThe Fly
FDA discloses summary of violations at Humacyte’s Durham, NC facility
23d ago
HUMA
Humacyte Launches $30M Stock and Warrants Offering
PremiumCompany AnnouncementsHumacyte Launches $30M Stock and Warrants Offering
1M ago
8K
HUMA
Humacyte to sell 5.68M shares at $5.28 in registered direct offering
Premium
The Fly
Humacyte to sell 5.68M shares at $5.28 in registered direct offering
1M ago
HUMA
Humacyte to participate in a conference call with Benchmark
Premium
The Fly
Humacyte to participate in a conference call with Benchmark
1M ago
HUMA
Humacyte announces allowance of U.S. patent covering BioVascular Pancreas
PremiumThe Fly
Humacyte announces allowance of U.S. patent covering BioVascular Pancreas
2M ago
HUMA
Humacyte initiated with a Buy at EF Hutton
PremiumThe Fly
Humacyte initiated with a Buy at EF Hutton
2M ago
HUMA
Hertz Global Holdings call volume above normal and directionally bullish
PremiumThe Fly
Hertz Global Holdings call volume above normal and directionally bullish
2M ago
HUMA
Humacyte presents long-term results of ATEV in vascular trauma
PremiumThe Fly
Humacyte presents long-term results of ATEV in vascular trauma
2M ago
HUMA
Small Cap Stocks: FDA Delay Created Buy-On-The-Dip Opportunity for Humacyte (HUMA)
PremiumMarket NewsSmall Cap Stocks: FDA Delay Created Buy-On-The-Dip Opportunity for Humacyte (HUMA)
3M ago
HUMA
Humacyte reports Q2 EPS (48c) , consensus (24c)
Premium
The Fly
Humacyte reports Q2 EPS (48c) , consensus (24c)
3M ago
HUMA
Texas probes CenterPoint, Carlyle weighs Nobian sale: Monday Buzz
Premium
The Fly
Texas probes CenterPoint, Carlyle weighs Nobian sale: Monday Buzz
3M ago
CG
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >